SCHEMBL6526308

SCHEMBL6526308

OC(CC1CCC2(CC1)OCCO2)N1Cc2ccccc2C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.38
HPGD P15428 1/20 0.38
NAMPT P43490 1/20 0.36
RECQL P46063 1/20 0.35
KMT2A Q03164 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
TSHR P16473 1/20 0.34
IDO1 P14902 1/20 0.34
PRMT5 O14744 3/20 0.34
WDR77 Q9BQA1 3/20 0.34
PARP1 P09874 1/20 0.34
C5AR1 P21730 1/20 0.33
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NPC1 O15118 1/20 0.33
MAPK1 P28482 1/20 0.33
CASP1 P29466 1/20 0.33
RAB9A P51151 1/20 0.33
CASP7 P55210 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1044566 0.73 PRMT5 (0.44) ALDH1A1HPGDRECQLIDO1PRMT5
Iodide SCHEMBL1968748 0.67 ALDH1A1 (0.35) ALDH1A1KMT2AL3MBTL1TSHRIDO1
SCHEMBL23095751 0.66 NAMPT (0.41) NAMPTPRMT5
SCHEMBL14430235 0.66 ACHE (0.49) ALDH1A1HPGDRECQL
SCHEMBL7067349 0.65 SMN1; SMN2 (0.51) ALDH1A1KMT2ATSHRMAPTMEN1
SCHEMBL9116396 0.65 GRIN1 (0.47) ALDH1A1HPGDRECQLPRMT5WDR77
SCHEMBL8990452 0.63 TSHR (0.43) ALDH1A1KMT2AL3MBTL1TSHRIDO1
SCHEMBL25415116 0.63 MAOA (0.44) MMP2MMP9MMP13
SCHEMBL1044565 0.63 MEN1 (0.44) ALDH1A1KMT2AL3MBTL1TSHRIDO1
SCHEMBL4876803 0.63 CXCR4 (0.52) ALDH1A1HPGDMAPTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288406-B2 Hydroxymethylcyclohexylamines GRUENENTHAL GMBH (DE) 2012-10-16 US disclosed
US-20110059999-A1 Hydroxymethylcyclohexylamines Grünenthal GmbH (DE) 2011-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059999-A1 Hydroxymethylcyclohexylamines OPRL1, OPRM1, OPRD1 ALDH1A1 610/4885HPGD 1870/4885NAMPT 3801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.